South Wales, Nov. 13 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "NexisQuant" on Nov. 3. The details about the trademark application no. UK00004469548 published in the journal no. 2026/046 (Nov. 13).

With HGF Limited as representative, BBI Solutions OEM Limited filed the trademark application for the below mentioned good(s)/service(s).

Class 5 : Recombinant alternatives; recombinant alternatives for in vitro diagnostics; immunoassay reagents for medical use; diagnostic reagents for medical use; immunoassay reagents for in vitro diagnostics; in vitro diagnostic tests and preparations for medical use; reagents for in-vitro laboratory use (for medical purposes); medical diagnostic reagents and assays for testing of body fluids; antibodies; human antibodies (recombinantly produced); antibodies for in-vitro diagnostic testing; recombinantly produced human rheumatoid factor antibodies; recombinantly produced human anti-thyroid peroxidase antibodies; reagents for medical use; medical diagnostic reagents; clinical medical reagents; clinical diagnostic reagents; clinical diagnostic reagents; chemical test reagents [medical]; raw reagents for medical diagnostic purposes; raw reagents for in vitro use; in vitro diagnostic preparations for medical use; diagnostic substances for medical use; diagnostic agents for medical use; diagnostic preparations for medical purposes; diagnostic preparations and materials for medical purposes; diagnostic preparations for medical purposes for use in medical laboratories.

The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004469548

Disclaimer: Curated by HT Syndication.